Literature DB >> 17967942

Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.

Jürgen Haas1, Laila Schopp, Brigitte Storch-Hagenlocher, Benedikt Fritzsching, Christian Jacobi, Linda Milkova, Brigitte Fritz, Alexander Schwarz, Elisabeth Suri-Payer, Manfred Hensel, Brigitte Wildemann.   

Abstract

Whereas regulatory T (Treg) cells play an important role in the prevention of autoimmunity, increasing evidence suggests that their down-regulatory properties negatively affect immune responses directed against tumors. Treg cells selectively express chemokine receptors CCR4 and CCR8, and specific migration occurs following the release of various chemokines. Neoplastic meningitis (NM) resulting from leptomeningeal spread of systemic non-Hodgkin lymphoma (NHL) or carcinoma has a poor prognosis. We hypothesized that Treg-cell accumulation within the subarachnoid space as a result of interfering with tumor immunity may be relevant for survival of neoplastic cells. We collected cerebrospinal fluid (CSF) from 101 patients diagnosed with lymphomatous/carcinomatous NM and various inflammatory diseases (IDs) and noninflammatory neurologic disorders (NIDs). CSF Treg- cell counts were determined by flow cytometry, Treg cell-specific chemokines by enzyme-linked immunosorbent assay (ELISA), and Treg-cell trafficking by chemotaxis assay. Both frequencies of Treg-cell and Treg cell-specific chemotactic activities were significantly elevated in CSF samples of patients with NM. Local Treg-cell accumulation occurred without concomitant rise of conventional T (Tconv) cells, coincided with elevated concentrations of Treg cell-attracting chemokines CCL17 and CCL22 and correlated with numbers of atypical CSF cells. We conclude that Treg cells are specifically recruited into the CSF of patients with NM, suggesting that the presence of Treg cells within the subarachnoid space generates a microenvironment that may favor survival and growth of malignant cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967942     DOI: 10.1182/blood-2007-08-104877

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  Regulatory T cell migration during an immune response.

Authors:  Yaozhong Ding; Jiangnan Xu; Jonathan S Bromberg
Journal:  Trends Immunol       Date:  2012-02-02       Impact factor: 16.687

2.  Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Authors:  Fang Hou; Qi-Ming Huang; Dan-Ning Hu; Jost B Jonas; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics.

Authors:  S Donnou; C Galand; C Daussy; L Crozet; W H Fridman; C Sautès-Fridman; S Fisson
Journal:  Clin Exp Immunol       Date:  2011-06-10       Impact factor: 4.330

Review 4.  Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

Authors:  V Kumar
Journal:  Purinergic Signal       Date:  2012-12-28       Impact factor: 3.765

Review 5.  Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

6.  NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells.

Authors:  Jens Loebbermann; Lydia Durant; Hannah Thornton; Cecilia Johansson; Peter J Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.

Authors:  Adam D Cohen; David A Schaer; Cailian Liu; Yanyun Li; Daniel Hirschhorn-Cymmerman; Soo Chong Kim; Adi Diab; Gabrielle Rizzuto; Fei Duan; Miguel A Perales; Taha Merghoub; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

9.  CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee; Jerry A Colliver; Richard M Ransohoff
Journal:  J Clin Immunol       Date:  2013-01-23       Impact factor: 8.317

10.  T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function.

Authors:  Yanbao Xiong; Sarwat Ahmad; Daiki Iwami; C Colin Brinkman; Jonathan S Bromberg
Journal:  J Immunol       Date:  2016-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.